Table 2.
Classification | Reagents | Targets | Impact on ferroptosis |
---|---|---|---|
Ferroptosis inducers | Sulphasalazine | System Xc- | Prevents cystine import, causes GSH depletion |
Sorafenib | System Xc- | Prevents cystine import, causes GSH depletion | |
Glutamate | System Xc- | Prevents cystine import, causes GSH depletion | |
Erastin and its analogs | System Xc-, VDAC2/3 | Prevents cystine import, causes GSH depletion | |
RSL3 | GPX4 | Covalent inhibitor of GPX4 that causes accumulation of lipid hydroperoxides |
|
ML162 | GPX4 | Covalent inhibitor of GPX4 that causes accumulation of lipid hydroperoxides |
|
FINO2 | GPX4 | Covalent inhibitor of GPX4 that causes accumulation of lipid hydroperoxides |
|
FIN56 | CoQ10 and GPX4 | Depletes CoQ10 via SQS-mevalonate pathway and causes decrease in GPX4 protein abundance |
|
BSO, DPI2, cisplatin | GHS | GHS deletion | |
Statins (e.g., cerivastatin, simvastatin) | HMGCR | Blocks CoQ10 biosynthesis | |
Trigonelline, brusatol | Nrf2 | Nrf2 inhibition | |
Siramesine, lapatinib | Ferroportin, Transferrin | Upregulates cellular iron | |
Brequinar | DHODH | Inhibits DHODH | |
iFSP | FSP1 | Inhibits FSP1 | |
BAY 87‐2243 | Mitochondrial respiratory chain | Inhibits mitochondrial respiratory chain | |
Andrographolide | Lipid peroxidation | Promotes lipid peroxidation | |
Toosendanin | Lipid peroxidation | Promotes lipid peroxidation | |
Gliotoxin | ROS, lipid peroxidation | Promotes lipid peroxidation | |
Arsenic trioxide | ACSL4 | ACSL4 activation | |
Manganese | ROS, lipid peroxidation | Promotes lipid peroxidation | |
Fatostatin | GPX4 | Inhibits GPX4 expression | |
Legumain | GPX4 | Facilitates chaperone-mediated autophagy of GPX4 | |
Dihydroartemisinin (DHA) | Ferritin, iron overload | Increases cellular iron | |
Artemisinins | Iron overload | Increases cellular iron | |
Ferroptosis inhibitors | Ferrostatin-1 | Lipid peroxidation | Blocks lipid peroxidation |
Liproxstatin-1 | Lipid peroxidation | Blocks lipid peroxidation | |
Vitamin E | Lipid peroxidation | Blocks lipid peroxidation | |
SRS 16-86, SRS 11-92 | Lipid peroxidation | Blocks lipid peroxidation | |
Troglitazone, Pioglitazone, Rosiglitazone | ACSL4 | ACSL4 inactivation | |
Deuterated polyunsaturated fatty acids (D-PUFAs) | Lipid peroxidation | Blocks lipid peroxidation | |
XJB-5-131 | Lipid peroxidation | Blocks lipid peroxidation | |
Butylated hydroxytoluene, butylated hydroxyanisole |
Lipid peroxidation | Blocks lipid peroxidation | |
Ferrostatins, liproxstatins | Lipid peroxidation | Blocks lipid peroxidation | |
CDC, PD-146176, AA-861, zileuton | Lipoxygenases | Blocks lipid peroxidation | |
Selenium | Selenoproteins | Blocks lipid peroxidation | |
Deferoxamine, cyclipirox, deferiprone | Intracellular iron | Decreases cellular iron | |
Vildagliptin, alogliptin, and Linagliptin | DPP4 | Blocks DPP4-mediated lipid peroxidation | |
Irisin | GPX4 | Upregulates GPX4 | |
Melatonin | System Xc- and GPX4 | Upregulates system Xc- and GPX4 | |
Vitexin | System Xc- and GPX4 | Upregulates system Xc- and GPX4 | |
Isoliquiritigenin | System Xc- and GPX4 | Upregulates system Xc- and GPX4 | |
Vitamin A | Lipid peroxidation | Blocks lipid peroxidation | |
Paricalcitol | GPX4 | Upregulates GPX4 | |
Pachymic acid | Nrf2, GPX4, SCL7A11, and HO-1 | Upregulates of Nrf2, GPX4, SCL7A11 and HO-1 | |
Rheb1 | Maintains mitochondrial homeostasis | Maintains mitochondrial homeostasis | |
Quercetin | System Xc- and GPX4 | Upregulates system Xc- and GPX4 | |
Artesunate | Lipoxygenases | Blocks lipid peroxidation | |
Curcumin | Lipoxygenases | Blocks lipid peroxidation | |
Baicalein | Lipoxygenases | Blocks lipid peroxidation | |
Nuciferine | Lipoxygenases | Blocks lipid peroxidation | |
Vitamin K | Lipid peroxidation | Blocks lipid peroxidation | |
Cardamonin | Lipid peroxidation | Blocks lipid peroxidation | |
Proanthocyanidins | Lipid peroxidation | Blocks lipid peroxidation | |
Uridine | Lipid peroxidation | Blocks lipid peroxidation | |
NDGA | Lipoxygenases | Blocks lipid peroxidation |